SCHEMBL8466217

SCHEMBL8466217

C[CH]C(c1cccnc1)c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A4 P31645 1/20 0.52
SLC6A3 Q01959 1/20 0.52
GOPC Q9HD26 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.46
CYP19A1 P11511 2/20 0.46
GAA P10253 1/20 0.44
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KCNN4 O15554 2/20 0.42
KCNA5 P22460 2/20 0.42
TSHR P16473 2/20 0.41
MAPT P10636 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2A6 P11509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1985149 0.81 CFTR (0.50) CFTRSLC6A2SLC6A4SLC6A3GOPC
SCHEMBL5667237 0.79 CFTR (0.48) CFTRSLC6A2SLC6A4SLC6A3GOPC
SCHEMBL30844922 0.75 CFTR (0.48) CFTRSLC6A2SLC6A4SLC6A3GOPC
SCHEMBL10446411 0.75 CFTR (0.58) CFTRSLC6A2SLC6A4SLC6A3GOPC
SCHEMBL10236 0.75
SCHEMBL30391667 0.75
SCHEMBL3887188 0.74 CFTR (0.62) CFTRSLC6A2SLC6A4SLC6A3GOPC
SCHEMBL28307922 0.74 CFTR (0.57) CFTRSLC6A2SLC6A4SLC6A3GOPC
SCHEMBL360712 0.74 CFTR (0.57) CFTRSLC6A2SLC6A4SLC6A3GOPC
Ammonia Solution, Strong SCHEMBL2569576 0.73 CFTR (0.56) CFTRSLC6A2SLC6A4SLC6A3GOPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0941113-A1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS Vertex Pharmaceuticals Incorporated (US) 1999-09-15 EP claimed
WO-1998020893-A1 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-05-22 WO claimed